These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9537420)

  • 1. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
    Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
    Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
    Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
    J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolae and caveolin-3 in muscular dystrophy.
    Galbiati F; Razani B; Lisanti MP
    Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia.
    Carbone I; Bruno C; Sotgia F; Bado M; Broda P; Masetti E; Panella A; Zara F; Bricarelli FD; Cordone G; Lisanti MP; Minetti C
    Neurology; 2000 Mar; 54(6):1373-6. PubMed ID: 10746614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
    Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C
    Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
    Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
    Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.
    Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C
    Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
    Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
    Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-3 in muscular dystrophy.
    McNally EM; de Sá Moreira E; Duggan DJ; Bönnemann CG; Lisanti MP; Lidov HG; Vainzof M; Passos-Bueno MR; Hoffman EP; Zatz M; Kunkel LM
    Hum Mol Genet; 1998 May; 7(5):871-7. PubMed ID: 9536092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
    Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
    Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).
    Muchir A; Bonne G; van der Kooi AJ; van Meegen M; Baas F; Bolhuis PA; de Visser M; Schwartz K
    Hum Mol Genet; 2000 May; 9(9):1453-9. PubMed ID: 10814726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
    Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF
    Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21.
    van der Kooi AJ; van Meegen M; Ledderhof TM; McNally EM; de Visser M; Bolhuis PA
    Am J Hum Genet; 1997 Apr; 60(4):891-5. PubMed ID: 9106535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-3 deficiency causes muscle degeneration in mice.
    Hagiwara Y; Sasaoka T; Araishi K; Imamura M; Yorifuji H; Nonaka I; Ozawa E; Kikuchi T
    Hum Mol Genet; 2000 Dec; 9(20):3047-54. PubMed ID: 11115849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of a novel caveolin-3 mutation in a large German family.
    Fischer D; Schroers A; Blümcke I; Urbach H; Zerres K; Mortier W; Vorgerd M; Schröder R
    Ann Neurol; 2003 Feb; 53(2):233-41. PubMed ID: 12557291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
    Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
    J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
    Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
    Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.
    Betz RC; Schoser BG; Kasper D; Ricker K; Ramírez A; Stein V; Torbergsen T; Lee YA; Nöthen MM; Wienker TF; Malin JP; Propping P; Reis A; Mortier W; Jentsch TJ; Vorgerd M; Kubisch C
    Nat Genet; 2001 Jul; 28(3):218-9. PubMed ID: 11431690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.